Skip to main content
Displaying 133 - 144 of 275
Display:
12
24
48
Liver Tumours
5
Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021
View
Liver Tumours
5
Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021
View
Liver Tumours
5
Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021
View
Liver Tumours
5
Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021
View
Liver Tumours
5
Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021
View
Metabolism, Alcohol & Toxicity
6
Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021
View
Metabolism, Alcohol & Toxicity
6
Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021
View
Metabolism, Alcohol & Toxicity
6
Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021
View
Metabolism, Alcohol & Toxicity
6
Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021
View
Metabolism, Alcohol & Toxicity
6
Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021
View
Metabolism, Alcohol & Toxicity
6
Echosens: Enhancing the management of NAFLD patients with FibroScan-based scores - ILC 2021
View
Metabolism, Alcohol & Toxicity
5
IMP: Shining a spotlight on obesity treatment in NAFLD/NASH - ILC 2021
View
Pagination
First page
« First
Previous page
‹ previous
…
Page
8
Page
9
Page
10
Page
11
Current page
12
Page
13
Page
14
Page
15
Page
16
…
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy